Search research articles
Contact Us
Filters
Showing results (361-370 of 376) with videos related to
Page
of 38
Sort By:
Nature Communications
|
June 12, 2023
Phase 1b trial of anti-EGFR antibody JMT101 and Osimertinib in EGFR exon 20 insertion-positive non-small-cell lung cancer
Shen Zhao, Wu Zhuang, Baohui Han, et al.
Journal of Virology
|
September 2, 2011
Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology
Pan Liu, Xiaodong Fang, Zizhen Feng, et al.
BMC Medicine
|
May 5, 2023
Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study
Jin Li, Shukui Qin, Lu Wen, et al.
The Lancet. Gastroenterology & Hepatology
|
May 10, 2021
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Shukui Qin, Qiu Li, Shanzhi Gu, et al.
The Oncologist
|
June 9, 2021
Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double-Blinded, Placebo-Controlled, Randomized Phase III Trial (ALTER0703)
Yihebali Chi, Yongqian Shu, Yi Ba, et al.
The Journal of Bone and Joint Surgery. American Volume
|
November 3, 2022
Autologous Costal Cartilage Grafting for a Large Osteochondral Lesion of the Femoral Head: A 1-Year Single-Arm Study with 2 Additional Years of Follow-up
Chang-Qing Zhang, Da-Jiang Du, Pei-Chun Hsu, et al.
BMC Public Health
|
January 21, 2014
Effect of aerobic exercise and low carbohydrate diet on pre-diabetic non-alcoholic fatty liver disease in postmenopausal women and middle aged men--the role of gut microbiota composition: study protocol for the AELC randomized controlled trial
Wu Yi Liu, Da Jiang Lu, Xia Ming Du, et al.
European Journal of Medical Research
|
October 30, 2025
Analysis of common treatment-related adverse events of donafenib and its correlation with efficacy: exploratory analysis of the ZGDH3 study
Feng Bi, Shukui Qin, Shanzhi Gu, et al.
Cancer Communications (London, England)
|
October 26, 2021
Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first-line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open-label, parallel controlled clinical study
Jie Zhang, Yueyin Pan, Qin Shi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 6, 2022
Efficacy and Safety of Limertinib (ASK120067) in Patients With Locally Advanced or Metastatic EGFR Thr790Met-Mutated NSCLC: A Multicenter, Single-Arm, Phase 2b Study
Yuankai Shi, Baolan Li, Lin Wu, et al.
Page
of 38
Search research articles
Search
Showing results (361-370 of 376) with videos related to
Sort By:
Page
of 38
Nature Communications
|
June 12, 2023
Phase 1b trial of anti-EGFR antibody JMT101 and Osimertinib in EGFR exon 20 insertion-positive non-small-cell lung cancer
Shen Zhao, Wu Zhuang, Baohui Han, et al.
Journal of Virology
|
September 2, 2011
Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology
Pan Liu, Xiaodong Fang, Zizhen Feng, et al.
BMC Medicine
|
May 5, 2023
Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study
Jin Li, Shukui Qin, Lu Wen, et al.
The Lancet. Gastroenterology & Hepatology
|
May 10, 2021
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Shukui Qin, Qiu Li, Shanzhi Gu, et al.
The Oncologist
|
June 9, 2021
Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double-Blinded, Placebo-Controlled, Randomized Phase III Trial (ALTER0703)
Yihebali Chi, Yongqian Shu, Yi Ba, et al.
The Journal of Bone and Joint Surgery. American Volume
|
November 3, 2022
Autologous Costal Cartilage Grafting for a Large Osteochondral Lesion of the Femoral Head: A 1-Year Single-Arm Study with 2 Additional Years of Follow-up
Chang-Qing Zhang, Da-Jiang Du, Pei-Chun Hsu, et al.
BMC Public Health
|
January 21, 2014
Effect of aerobic exercise and low carbohydrate diet on pre-diabetic non-alcoholic fatty liver disease in postmenopausal women and middle aged men--the role of gut microbiota composition: study protocol for the AELC randomized controlled trial
Wu Yi Liu, Da Jiang Lu, Xia Ming Du, et al.
European Journal of Medical Research
|
October 30, 2025
Analysis of common treatment-related adverse events of donafenib and its correlation with efficacy: exploratory analysis of the ZGDH3 study
Feng Bi, Shukui Qin, Shanzhi Gu, et al.
Cancer Communications (London, England)
|
October 26, 2021
Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first-line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open-label, parallel controlled clinical study
Jie Zhang, Yueyin Pan, Qin Shi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 6, 2022
Efficacy and Safety of Limertinib (ASK120067) in Patients With Locally Advanced or Metastatic EGFR Thr790Met-Mutated NSCLC: A Multicenter, Single-Arm, Phase 2b Study
Yuankai Shi, Baolan Li, Lin Wu, et al.
Page
of 38